| URL | https://www.pharmtech.com/view/reshoring-and-expan |
| Source | Pharmtech |
| Date Published | 04/02/2021 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Cascade Chemistry |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | In-house |
| State(s) reshored to: | OR |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | API, pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |